Viewing Study NCT01685203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2026-02-24 @ 3:53 PM
Study NCT ID: NCT01685203
Status: COMPLETED
Last Update Posted: 2021-07-30
First Post: 2012-09-12
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C, Chronic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis C Virus View
None Ribavirin-Free View
None Hepatitis C Genotype 1 View
None Hepatitis C View
None Interferon-Free View
None Chronic Hepatitis C View
None Compensated cirrhosis View
None Hepatitis C Genotype 4 View
None Paritaprevir View
None Ombitasvir View
None Ritonavir View
None Ribavirin View